Medical Knowledge Sharing

Medical

This is not science fiction! The robot successfully repaired the pig's damaged esophagus

In today's rapidly changing world of science and technology, a research result that sounds very sci-fi will appear from time to time. No, a paper published in the journal Science Robotics belongs to this scope: a cell regeneration robot that successfully works in vivo.

Medical

New Study: Nmn Supplementation Activates Longevity Proteins To Reduce Stem Cell Senescence And Restore Mitochondrial Function

The development of an effective anti-aging drug and functional food to slow down ASCs' aging is crucial

Disease

What Happens When Eye Cancer Usually Spreads? What Exactly Are The Symptoms Of Eye Cancer?

Eye cancer is a very dangerous disease, and as the disease develops, it will affect the patient's body more and more, so it is important for eye cancer patients to receive timely treatment.

Apparatus

New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu

The FDA granted priority review status to Enhertu (DS-8201) for the treatment of patients with HR-positive, low HER2-expressing breast cancer, and Enhertu has enabled these patients to remain disease-free for an average of 10.1 months, with an average overall survival time of nearly two years. A decision on approval is expected to be made in the fourth quarter of this year.

Apparatus

Two-Drug Combination For Refractory Thyroid Cancer, 100% Effective!

Data from a study presented at the annual meeting of the European Society of Medical Oncology in 2022 showed that lenvatinib in combination with Pembrolizumab could give 100% efficacy in this group of patients.

Apparatus

Two-Drug Combination For Specific Mutation Colorectal Cancer With 100% Efficiency!

A study at Massachusetts General Hospital in the US demonstrated that Adagrasib alone and in combination with cetuximab delivered good results in patients with advanced colorectal cancer with KRAS G12C mutations, with 46% of subjects experiencing substantial tumour shrinkage and an efficacy rate of 100%.